If youre considering or already taking a GLP-1 agonist, its best to discuss your individual situation with your oncologist or primary care team, especially if you have other risk factors
If you dont wait, Rybelsus absorption drops, and the medication becomes less effective
Novo Nordisk A/S, Bagsvrd, Denmark) is the newest medication approved for chronic weight management
The core concept of all these studies is to pair an anorectic agent (GLP-1 or GLP-1/GIP) with an anabolic agent, such as anti-myostatin or bimagrumab
Possible side effects of IGF-1 DES can include [1, 16]: Impaired glucose metabolism and hypoglycemia Fatigue Changes in sexual function Swelling of soft tissues Hyperandrogenism Muscle and joint pain Fluid retention Gynecomastia Orthostatic hypotension One of the more serious side effects of prolonged IGF-1 DES administration is acromegalic cardiomyopathy (enlargement and weakening of the heart)
Presence of severe infection, malignancy, recent major surgery, or trauma